Rational combination of MEK inhibitor and the STAT3 pathway modulator for the therapy in K-Ras mutated pancreatic and colon cancer cells

K-Ras mutations are frequently detected in pancreatic and colon cancers, which are associated with the resistance to MEK inhibitors targeting the Ras pathway. Identifying the underlying mechanisms for the acquired resistance is essential for the future clinical development of MEK inhibitors. Here, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Chengguang, Xiao, Hui, Wu, Xiaojuan, Li, Chenglong, Liang, Guang, Yang, Shulin, Lin, Jiayuh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546480/
https://www.ncbi.nlm.nih.gov/pubmed/25961376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546480/
https://www.ncbi.nlm.nih.gov/pubmed/25961376

Ejemplares similares